Overview

Lobular carcinoma in situ is a noninvasive breast condition in which abnormal cells are found in the lobules, the milk-producing glands of the breast. Despite its name, lobular carcinoma in situ is not a true cancer but rather a marker indicating an increased risk of developing invasive breast cancer in the future. It is often discovered incidentally during a breast biopsy performed for another reason, as it typically does not form a lump or show clear symptoms.

Symptoms

Lobular carcinoma in situ usually does not cause noticeable symptoms and is rarely detected through physical examination. In most cases:

  • No breast lump is felt

  • No pain or discomfort is present

  • No visible breast changes occur

It is commonly identified through biopsy after abnormal findings on imaging tests.

Causes

The exact cause of lobular carcinoma in situ is not fully understood. It develops when abnormal cell growth occurs within the lobules of the breast. Hormonal influences, particularly estrogen exposure, are believed to play a role in the development of these abnormal cells. Genetic factors may also contribute in some individuals.

Risk Factors

Certain factors increase the likelihood of developing lobular carcinoma in situ:

  • Family history of breast cancer

  • Personal history of benign breast conditions

  • Early onset of menstruation

  • Late menopause

  • Hormone replacement therapy

  • Increasing age

Having lobular carcinoma in situ increases the risk of developing invasive breast cancer in either breast.

Complications

Although lobular carcinoma in situ itself is not life-threatening, it can lead to important long-term considerations:

  • Increased lifetime risk of invasive breast cancer

  • Need for more frequent breast monitoring

  • Emotional stress or anxiety related to cancer risk

  • Possible decisions regarding preventive treatments

Careful follow-up is essential to detect any future changes early.

Prevention

There is no guaranteed way to prevent lobular carcinoma in situ, but certain strategies may reduce the risk of progression to invasive breast cancer:

  • Regular clinical breast exams and imaging as recommended

  • Maintaining a healthy body weight

  • Limiting alcohol consumption

  • Discussing risk-reducing medications with a healthcare provider

  • Considering preventive surgery in high-risk cases

Close surveillance and informed decision-making help manage the long-term risks associated with lobular carcinoma in situ.

Request an appointment

Advertisement

Advertisement